rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5117
|
pubmed:dateCreated |
1993-7-27
|
pubmed:abstractText |
Type I diabetes [insulin-dependent diabetes mellitus (IDDM)] is an autoimmune disease associated with the destruction of pancreatic beta cells. Serum from patients with IDDM increased L-type calcium channel activity of insulin-producing cells and of GH3 cells derived from a pituitary tumor. The subsequent increase in the concentration of free cytoplasmic Ca2+ ([Ca2+]i) was associated with DNA fragmentation typical of programmed cell death or apoptosis. These effects of the serum were prevented by adding a blocker of voltage-activated L-type Ca2+ channels. When the serum was depleted of immunoglobulin M (IgM), it no longer affected [Ca2+]i. An IgM-mediated increase in Ca2+ influx may thus be part of the autoimmune reaction associated with IDDM and contribute to the destruction of beta cells in vivo.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0036-8075
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
261
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
86-90
|
pubmed:dateRevised |
2007-3-19
|
pubmed:meshHeading |
pubmed-meshheading:7686306-3-Pyridinecarboxylic acid...,
pubmed-meshheading:7686306-Animals,
pubmed-meshheading:7686306-Apoptosis,
pubmed-meshheading:7686306-Calcium,
pubmed-meshheading:7686306-Calcium Channels,
pubmed-meshheading:7686306-DNA Damage,
pubmed-meshheading:7686306-Diabetes Mellitus, Type 1,
pubmed-meshheading:7686306-Humans,
pubmed-meshheading:7686306-Immunoglobulin M,
pubmed-meshheading:7686306-Islets of Langerhans,
pubmed-meshheading:7686306-Membrane Potentials,
pubmed-meshheading:7686306-Mice,
pubmed-meshheading:7686306-Pituitary Neoplasms,
pubmed-meshheading:7686306-Tumor Cells, Cultured,
pubmed-meshheading:7686306-Verapamil
|
pubmed:year |
1993
|
pubmed:articleTitle |
Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes.
|
pubmed:affiliation |
Rolf Luft Center for Diabetes Research, Department of Endocrinology, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|